Related Experiment Videos
[Long-term effects and life expectancy after six years intermittent self ventilation]
G Laier-Groeneveld1, C P Criée
1Ev. Krankenhaus Lenglern, Universität Göttingen, Bovenden-Lenglern.
Medizinische Klinik (Munich, Germany : 1983)
|April 1, 1995
Summary
Intermittent mechanical ventilation effectively treats hypercapnic ventilatory failure. This therapy improves survival rates for patients with chest wall disorders and COPD, similar to those without ventilatory issues.
Area of Science:
- Pulmonary Medicine
- Critical Care Medicine
Context:
- Persistent ventilatory failure and symptoms despite medical treatment necessitate advanced interventions.
- Intermittent mechanical ventilation (IMV) is explored for patients with chronic respiratory conditions.
Purpose:
- To evaluate the efficacy of IMV in patients with persistent ventilatory failure.
- To assess survival rates in patients with chest wall disorders and COPD treated with IMV.
Summary:
- 381 patients with persistent ventilatory failure received IMV for up to 6 years.
- Patients with chest wall disorders showed over 95% survival.
- COPD patients experienced survival rates of 75% in year 2 and 59% in year 4.
Impact:
- IMV can normalize hypercapnic ventilatory failure.
- IMV demonstrates a survival benefit comparable to control groups without ventilatory failure.
- This approach offers a viable treatment for severe respiratory failure, improving patient outcomes.